Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Aisthesis Medical

Revolutionizing acute and critical care

## Sitemaps

- [XML Sitemap](https://aisthesismed.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Aisthesis Medical Wins Partnership with the NHS Award at 2026 Medilink UK National Awards](https://aisthesismed.com/aisthesis-medical-wins-partnership-with-the-nhs-award-at-2026-medilink-uk-national-awards/) - We are proud to announce that Aisthesis Medical has won the Partnership with the NHS Award at the 2026 Medilink UK National Awards, held on 9th July at Victoria House in London. This national recognition follows our success at the 2026 SEHTA Healthcare Business Awards, where we won the same category and were subsequently selected to represent the
- [Aisthesis Medical Wins Industry-Led Innovation Award at the Medipex NHS Innovation Awards 2026](https://aisthesismed.com/aisthesis-medical-wins-industry-led-innovation-award-at-the-medipex-nhs-innovation-awards-2026/) - We are proud to share that Aisthesis Medical has won the Industry-Led Innovations to Address Patient Safety Challenges category at the Medipex NHS Innovation Awards and Showcase 2026, held online on 24th June. The award recognised VIOSync — AI Digital Twin for 48-Hour Sepsis Prediction, selected from a field of five finalists in a category
- [Aisthesis Medical Wins Partnership with the NHS Award at 2026 SEHTA Healthcare Business Awards](https://aisthesismed.com/aisthesis-medical-wins-partnership-with-the-nhs-award-at-2026-sehta-healthcare-business-awards/) - We are proud to share that Aisthesis Medical has won the Partnership with the NHS Award at the 2026 SEHTA Healthcare Business Awards, held on 26th May at Scale Space, Imperial College London. We were also recognised as Runner-up in the Advances in Digital Healthcare category — two recognitions that reflect the clinical rigour, NHS
- [Aisthesis Medical Selected for Innovate UK Global Incubator Programme – Canada AI for Health](https://aisthesismed.com/aisthesis-medical-selected-for-innovate-uk-global-incubator-programme-canada-ai-for-health/) - We've been selected for the Innovate UK Global Incubator Programme in partnership with MaRS Discovery District – joining just 8 UK companies chosen to accelerate AI healthcare innovation in the Canadian market. The six-month programme (September 2025 – March 2026) connects us directly with North America's largest urban innovation hub, giving VIOSync access to hospitals,
- [Aisthesis Medical raises $1.2M pre-seed funding to transform sepsis prediction with AI-powered clinical decision support](https://aisthesismed.com/aisthesis-medical-raises-1-2m-pre-seed-funding-to-transform-sepsis-prediction-with-ai-powered-clinical-decision-support/) - [London, 01/10/2025] — Aisthesis Medical, a UK-based healthtech startup developing hospital-grade AI clinical decision-support software, today announced the successful closing of a $1.2M (£900K) pre-seed funding round, led by TwinPath Ventures with participation from TECS Capital. The funding will accelerate the development and regulatory clearance of VIOSync SPI, an AI-powered clinical decision support platform that
- [Aisthesis Medical Sponsors the 12th Sepsis Update and Presents New Research](https://aisthesismed.com/aisthesis-medical-sponsors-the-12th-sepsis-update-and-presents-new-research/) - On 2–4 October at the ATLANTIC Hotel in Heidelberg, we joined Europe's foremost sepsis clinical community to share fresh research on VIOSync and ask a question that drives everything we do: how can we make insight move faster than deterioration? Sepsis doesn't wait. It deteriorates in hours, not days — and the window to intervene
- [VIOSync at ESICM LIVES 2025: Bringing Foresight ICU Teams Can Trust](https://aisthesismed.com/viosync-at-esicm-lives-2025-bringing-foresight-icu-teams-can-trust/) - At the European Society of Intensive Care Medicine's annual congress, we shared the latest updates on how VIOSync delivers earlier, explainable sepsis insight — directly inside the clinical workflow, where it matters most. There's a problem at the centre of intensive care medicine that technology has so far failed to solve well: ICU teams are
- [VIOSync Takes the Global Stage: What We Learned at SWITCH 2025](https://aisthesismed.com/viosync-takes-the-global-stage-what-we-learned-at-switch-2025/) - From pitching at Microsoft's Singapore office to conversations with APAC health systems — our week at the Singapore Week of Innovation and Technology (SWITCH) confirmed what clinical partners worldwide are looking for from AI in healthcare. We're back from Singapore — energised, grateful, and with a clearer picture than ever of where clinical AI needs
- [Aisthesis Medical Selected for Innovate UK Biomedical Catalyst Accelerator: MedTech Venture Kickstarter](https://aisthesismed.com/aisthesis-medical-selected-for-innovate-uk-biomedical-catalyst-accelerator-medtech-venture-kickstarter/) - Chosen from across the UK as one of just 10 high-potential MedTech ventures, we're joining a prestigious 4-month programme designed to sharpen our go-to-market strategy, de-risk adoption, and scale VIOSync. We're proud to announce that Aisthesis Medical has been selected for the Innovate UK Biomedical Catalyst Accelerator: MedTech Venture Kickstarter — delivered by the London
- [Aisthesis Medical Named a Top 15 Medical Start-Up of 2025 at MEDICA](https://aisthesismed.com/aisthesis-medical-named-a-top-15-medical-start-up-of-2025-at-medica/) - Selected from 230+ global submissions, we've been recognised by the world's leading healthcare trade fair for bringing earlier, explainable sepsis detection to real clinical workflows. We're proud to share that Aisthesis Medical has been named one of the Top 15 Medical Start-Ups of 2025 by the MEDICA Start-Up Competition — selected in the highly competitive
- [Aisthesis Medical Is Now ISO 13485:2016 Certified](https://aisthesismed.com/aisthesis-medical-is-now-iso-134852016-certified/) - Our Quality Management System now meets the highest international standard for medical device quality — a critical milestone on our path to CE MDR and scaled clinical deployment of VIOSync. We did it. Aisthesis Medical is officially ISO 13485:2016 certified — and we couldn't be more proud of what this represents for our team, our
- [Aisthesis Medical Achieves UK Cyber Essentials Plus Certification](https://aisthesismed.com/aisthesis-medical-achieves-uk-cyber-essentials-plus-certification/) - How our government-backed security certification strengthens trust for NHS procurement and enterprise AI deployment. We're proud to share a significant milestone for Aisthesis Medical: we've achieved UK Cyber Essentials Plus certification, one of the most rigorous cybersecurity standards available in the UK, backed by the National Cyber Security Centre (NCSC) and the UK government. For
- [Aisthesis Medical Selected for Tech Tour AI for Health 2026](https://aisthesismed.com/aisthesis-medical-selected-for-tech-tour-ai-for-health-2026/) - We're excited to announce that Aisthesis Medical has been selected to present at Tech Tour AI for Health 2026, one of Europe's leading investor-driven platforms for companies applying AI to real clinical challenges. This selection places us among a competitive cohort of innovators working across prevention, diagnostics, treatment, and acute care. We'll be in Bochum
- [Aisthesis Medical Appoints Dr. Iain Miller as Non-Executive Director and Chair of the Board](https://aisthesismed.com/aisthesis-medical-appoints-dr-iain-miller-as-non-executive-director-and-chair-of-the-board/) - Aisthesis Medical, a healthcare technology company developing AI-powered clinical decision support systems for acute and critical care, today announced the appointment of Dr. Iain Miller as Non-Executive Director and Chair of the Board. Dr. Miller brings over 30 years of leadership experience across the diagnostics and MedTech sectors, having held senior positions at GE Healthcare,
- [Aisthesis Medical Achieves NHS Data Security and Protection Toolkit 'Standards Exceeded' Status](https://aisthesismed.com/aisthesis-medical-achieves-nhs-data-security-and-protection-toolkit-standards-exceeded-status/) - We've achieved 'Standards Exceeded' status in the NHS Data Security and Protection Toolkit (DSPT), the highest tier of NHS data security certification. Awarded February 23, 2026, this certification validates that Aisthesis Medical meets advanced data protection and cybersecurity standards required for handling NHS patient data, positioning VIOSync for deployment in NHS environments. What is the
- [Aisthesis Medical Named Finalist in Three Categories at 2026 SEHTA Healthcare Business Awards](https://aisthesismed.com/aisthesis-medical-named-finalist-in-three-categories-at-2026-sehta-healthcare-business-awards/) - We've been selected as a finalist in three categories at the 2026 SEHTA Healthcare Business Awards, recognizing VIOSync across Start-up, Partnership with the NHS, and Advances in Digital Healthcare. The awards ceremony takes place on 23rd April 2026 at Scale Space, Imperial College London, bringing together the region's leading healthtech companies, NHS trusts, academic institutions,
- [Aisthesis Medical Selected to Pitch at HTGF MedTech Pitch Day 2026](https://aisthesismed.com/aisthesis-medical-selected-to-pitch-at-htgf-medtech-pitch-day-2026/) - We've been selected to pitch at HTGF MedTech Pitch Day 2026, one of Europe's most competitive investor events for medical technology startups. From approximately 100 applications across 14 countries, we're among the companies chosen to present VIOSync to leading MedTech investors and corporate decision-makers on March 17th in Freiburg, Germany. About HTGF MedTech Pitch Day
- [Aisthesis Medical Joins Caelestinus Global HealthTech Incubator](https://aisthesismed.com/aisthesis-medical-joins-caelestinus-global-healthtech-incubator/) - We've been accepted into Caelestinus, a global healthtech incubator focused on FHIR interoperability and digital health data standards. Over the next three months (March-June 2026), we'll be working with InterSystems, IKEM (Europe's largest transplant center), and leading healthcare technology experts to integrate VIOSync into the interoperability infrastructure that enables clinical AI systems to actually deploy
- [Aisthesis Medical Showcases VIOSync at HLTH Europe 2025](https://aisthesismed.com/aisthesis-medical-showcases-viosync-at-hlth-europe-2025/) - We were proud to showcase our flagship platform, VIOSync®, at the UK Business & Trade Pavilion, alongside some of the UK’s most promising healthtech companies. Aisthesis Medical had the privilege of exhibiting at HLTH Europe 2025, one of the continent’s premier gatherings of health innovation leaders. Hosted in Amsterdam, this year’s event brought together global
- [Aisthesis Medical Joins NVIDIA Inception Programme to Advance AI-Driven Sepsis Innovation](https://aisthesismed.com/aisthesis-medical-joins-nvidia-inception-programme-to-advance-ai-driven-sepsis-innovation/) - Collaboration with NVIDIA Inception represents a significant milestone in Aisthesis Medical’s mission to transform acute care with artificial intelligence. We are pleased to announce that Aisthesis Medical has been accepted into the NVIDIA Inception Programme, a prestigious global initiative that supports high-potential startups harnessing the power of AI to drive innovation. NVIDIA Inception offers a unique
- [Aisthesis Medical Awarded Eureka Innowwide Grant to Advance Sepsis Prediction in the US](https://aisthesismed.com/aisthesis-medical-awarded-eureka-innowwide-grant-to-advance-sepsis-prediction-in-the-us/) - Through the Innowwide-supported CareSync project, we will strengthen the external validation of our technology in a new care setting. Aisthesis Medical is proud to announce that we’ve been awarded a EUREKA Innowwide Grant for our international collaboration project, Next-Generation AI Screening Tool for Sepsis Detection and Prevention. This competitive grant supports cross-border innovation partnerships and
- [Aisthesis Medical Awarded Grant for the MedTech Accelerator: Rapid Regulatory Support (MARRS) Programme](https://aisthesismed.com/aisthesis-medical-awarded-grant-for-the-medtech-accelerator-rapid-regulatory-support-marrs-programme/) - By enabling early detection, optimized clinical workflows, and reduced antibiotic overuse, VIOSync is poised to transform sepsis care We are excited to share that Aisthesis Medical has been selected for the MARRS Programme by CPI UK, an initiative designed to accelerate regulatory pathways for cutting-edge MedTech innovations. This support will be instrumental in fast-tracking the
- [Revolutionizing Postoperative Care: The PRISM Study Unveiled](https://aisthesismed.com/revolutionizing-postoperative-care-the-prism-study-unveiled/) - Innovative Approaches to Enhancing Postoperative Sepsis Management Aisthesis Medical, in partnership with Larissa University Hospital, proudly leads the cutting edge of medical research with our ongoing PRISM study. This initiative represents our unwavering commitment to transforming postoperative care through the power of predictive analytics. Launched on November 29, 2023, the PRISM study is dedicated to
- [Aisthesis Medical Selected as Finalist for Rewired25 Pitchfest](https://aisthesismed.com/aisthesis-medical-selected-as-finalist-for-rewired25-pitchfest/) - This prestigious competition showcases the most promising startups transforming digital health We are thrilled to announce that Aisthesis Medical has been selected as a finalist in the Pre-Revenue category for the Rewired25 Pitchfest, taking place at Digital Health Rewired 2025! This prestigious competition showcases the most promising startups transforming digital health, providing a platform for
- [Aisthesis Medical Receives SME Innovation Voucher Award for AI-Driven Sepsis Prediction Validation](https://aisthesismed.com/aisthesis-medical-receives-sme-innovation-voucher-award-for-ai-driven-sepsis-prediction-validation/) - At Aisthesis Medical, we are committed to transforming sepsis care through AI-driven early detection We are proud to announce that Aisthesis Medical has been awarded the City St George’s University of London SME Innovation Voucher Award to conduct a retrospective external clinical validation of our VIOSync Sepsis Prediction Index, in collaboration with St George’s Hospital. Why This Matters Sepsis remains one of the
- [Aisthesis Medical Selected for Tech Tour AI for Health 2025](https://aisthesismed.com/aisthesis-medical-selected-for-tech-tour-ai-for-health-2025/) - At Aisthesis Medical, we are committed to advancing AI-powered solutions that make healthcare more efficient, accessible, and life-saving. We are proud to announce that Aisthesis Medical has been selected to present at the 1st edition of Tech Tour AI for Health event, taking place on January 22-23 in Bochum, Germany. The event focuses on showcasing innovative companies
- [Aisthesis Medical Joins Innovate UK’s Global Business Innovation Programme on AMR in Switzerland](https://aisthesismed.com/aisthesis-medical-joins-innovate-uks-global-business-innovation-programme-on-amr-in-switzerland/) - At Aisthesis Medical, we believe the key to addressing AMR in sepsis care lies in prevention, precision, and timely intervention. We are delighted to announce that Aisthesis Medical has been selected as part of the UK delegation for the Innovate UK Antimicrobial Resistance (AMR) Global Business Innovation Programme in Switzerland! This prestigious initiative brings together
- [Aisthesis Medical Joins SEHTA to Accelerate Healthcare Innovation!](https://aisthesismed.com/aisthesis-medical-joins-sehta-to-accelerate-healthcare-innovation/) - SEHTA’s membership provides us with the strategic leverage we need to drive our vision forward We’re excited to announce that Aisthesis Medical is now a proud member of SEHTA—the Science and Engineering Health Technologies Alliance. SEHTA is one of the largest and most respected healthcare technology networks in Europe, offering its members access to a wealth
- [Aisthesis Medical Joins Barclays Eagle Labs Funding Readiness Programme](https://aisthesismed.com/aisthesis-medical-joins-barclays-eagle-labs-funding-readiness-programme/) - Being part of Barclays Eagle Labs’ network it’s about connecting with a diverse ecosystem of entrepreneurs, corporate partners, and key stakeholders We are excited to announce that Aisthesis Medical has been selected to participate in the prestigious Barclays Eagle Labs Funding Readiness Programme! Why This Matters This program, powered by Capital Enterprise, is specifically designed to
- [Aisthesis Medical Amongst the Top 10 Finalists of HealthTech Challengers 2024!](https://aisthesismed.com/aisthesis-medical-amongst-the-top-10-finalists-of-healthtech-challengers-2024/) - Aisthesis Medical is transforming acute care management through early sepsis prediction We’re thrilled to announce that Aisthesis Medical has been named one of the Top 10 Finalists in the AI-Supported Healthcare Track of the prestigious HealthTech Challengers 2024 competition! Why This Matters This recognition highlights the innovation and impact of our AI-powered solution, VIOSync, which is transforming acute care management
- [Aisthesis Medical Named as a Finalist for EIT Health InnoStars Awards 2024](https://aisthesismed.com/aisthesis-medical-named-as-a-finalist-for-eit-health-innostars-awards-2024/) - Aisthesis Medical will participate in a four-month mentoring program and will compete in the Grand Final We are proud to announce that Aisthesis Medical has been selected as one of the 20 finalists in the EIT Health InnoStars Awards 2024—Validation Track! This prestigious recognition highlights our dedication to improving patient outcomes through our AI-powered early sepsis
- [Aisthesis Medical to Present E-Poster at ESICM 2024 in Barcelona](https://aisthesismed.com/aisthesis-medical-to-present-e-poster-at-esicm-2024-in-barcelona/) - Aisthesis Medical specializes in AI-driven healthcare technology focused on enhancing clinical decision-making We are thrilled to announce that Aisthesis Medical will be participating in the 37th Annual Congress of the European Society of Intensive Care Medicine (ESICM), taking place from October 5-9 in Barcelona! Our Co-founder and COO, Dr. Vasileios Dimakopoulos, will be presenting an e-poster
- [Aisthesis Medical participates as an exhibitor at the InnoHealth Forum 2024](https://aisthesismed.com/aisthesis-medical-participates-as-an-exhibitor-at-the-innohealth-forum-2024/) - Aisthesis Medical Showcases Cutting-Edge Medical Technology at InnoHealth Forum Aisthesis Medical, proudly announces its successful participation as an exhibitor at the InnoHealth Forum held at JOIST Innovation Park. The InnoHealth Forum is a premier event that gathers healthcare innovators, industry leaders, and professionals to explore the latest advancements in medical technology. Aisthesis Medical's involvement underscored its commitment
- [Aisthesis Medical is excited to announce its participation in the BIO3 2024 conference's prestigious pitching event](https://aisthesismed.com/aisthesis-medical-is-excited-to-announce-its-participation-in-the-bio3-2024-conferences-prestigious-pitching-event/) - Aisthesis Medical’s participation in BIO3 2024 underscores its commitment to advancing acute care through AI and predictive analytics Aisthesis Medical, an innovative healthcare technology company specializing in AI-driven early sepsis prediction, is excited to announce its participation in the BIO3 2024 conference's prestigious pitching event. Organized by the BioInnovation Greece, this event will take place during the Biomedicine, Bioinformatics
- [Aisthesis Medical Joins the Ready2Scale Acceleration Program to Advance Medical Innovation](https://aisthesismed.com/aisthesis-medical-joins-the-ready2scale-acceleration-program-to-advance-medical-innovation/) - Aisthesis Medical is committed to advancing healthcare through innovative medical technologies Aisthesis Medical, a cutting-edge medical technology startup specializing in AI-driven diagnostic solutions, is thrilled to announce its acceptance into the prestigious Ready2Scale Acceleration Program. The Ready2Scale program, known for propelling high-potential startups to the next level, will provide Aisthesis Medical with invaluable resources, mentorship, and
- [Discover Aisthesis Medical at the Health.Tech Conference](https://aisthesismed.com/discover-aisthesis-medical-at-the-health-tech-conference/) - Learn about our AI-driven solution that is setting new standards in acute care management We are thrilled to announce that Aisthesis Medical will be participating in the upcoming Health.Tech Conference, a key event for healthcare technology innovators and professionals. The conference, known for showcasing cutting-edge advancements in healthcare, will be an excellent platform for us to
- [Join Aisthesis Medical at the Radical Health Festival](https://aisthesismed.com/join-aisthesis-medical-at-the-radical-health-festival/) - Learn how our innovative solutions can be integrated into healthcare systems to save lives and reduce costs We are excited to announce that Aisthesis Medical will be participating in the upcoming Radical Health Festival, a premier event that brings together innovators and thought leaders in the healthcare industry. This event will take place at Helsinki,
- [Aisthesis Medical Showcases Groundbreaking Sepsis Prediction Study at Euroanaesthesia 2024](https://aisthesismed.com/aisthesis-medical-showcases-groundbreaking-sepsis-prediction-study-at-euroanaesthesia-2024/) - Enhancing postoperative care by using wrist-wearable devices to predict sepsis We are excited to announce that Aisthesis Medical will be participating in the upcoming Euroanaesthesia 2024. Our latest study focuses on enhancing postoperative care by using wrist-wearable devices to predict sepsis early, aiming to transform patient outcomes in surgical wards. Study Overview Our research employs cutting-edge
- [Aisthesis Medical to Pitch at the EU Startups Summit 2024](https://aisthesismed.com/aisthesis-medical-to-pitch-at-the-eu-startups-summit-2024/) - Aisthesis Medical is leading the way in utilizing AI to enhance healthcare outcomes We are proud to announce that Aisthesis Medical has been selected as a finalist for the prestigious EU Startups Summit 2024. This event gathers the brightest and most innovative startups from across Europe, and being named a finalist is a significant honor that
- [Aisthesis Medical Among Top 15% Companies at MedTech Innovator](https://aisthesismed.com/aisthesis-medical-among-top-15-companies-at-medtech-innovator/) - Aisthesis Medical is leading the way in utilizing AI to enhance healthcare outcomes We are thrilled to announce that Aisthesis Medical has been selected as one of the top 15% of startups by MedTech Innovator, the largest accelerator of medical devices in the world. This prestigious recognition highlights our commitment to pushing the boundaries of
- [Aisthesis Medical Awarded DESIRE Grant for e-Health Innovation](https://aisthesismed.com/aisthesis-medical-awarded-desire-grant-for-e-health-innovation/) - Aisthesis Medical is leading the way in utilizing AI to enhance healthcare outcomes We are thrilled to announce that Aisthesis Medical has been selected as a recipient of the DESIRE grant. This grant endorses our mission to build resilience in healthcare and facilitate essential green and digital transitions. The grant enables us to perform crucial
- [Aisthesis Medical Takes the Spotlight in Naftemboriki Interview](https://aisthesismed.com/aisthesis-medical-takes-the-spotlight-in-naftemboriki-interview/) - Aisthesis Medical is leading the way in utilizing AI to enhance healthcare outcomes We're excited to share that our Co-founder and CEO, Ioannis Gkouzionis, recently featured in an enlightening interview with Naftemboriki, where he delved into the innovative strides Aisthesis Medical is making in the battle against sepsis. In the interview, Ioannis shed light on
- [A Leap Forward in Postoperative Sepsis Prediction: The PRISM Study](https://aisthesismed.com/a-leap-forward-in-postoperative-sepsis-prediction-the-prism-study/) - Aisthesis Medical Prediction of Sepsis in Patients Undergoing Abdominal Surgery: A Prospective, Observational Clinical Study Aisthesis Medical is at the forefront of medical innovation with its ongoing PRISM study, aimed at revolutionizing postoperative care through advanced predictive analytics. In collaboration with the Larissa University Hospital, this study underscores our commitment to improving patient outcomes and
- [Startups Showcase at Intelligent Health AI 2023](https://aisthesismed.com/startups-showcase-at-intelligent-health-ai-2023/) - Aisthesis Medical Shortlisted as a Finalist at Intelligent Health AI 2023! We are elated to share the fantastic news with our community! Aisthesis Medical has been chosen as one of the five esteemed finalists for the acclaimed Startups Showcase at Intelligent Health AI 2023, set to take place from 13th-14th September in Basel, Switzerland. Our
- [Funding for Sepsis Monitoring Project](https://aisthesismed.com/funding-for-sepsis-monitoring-project/) - Aisthesis Medical Receives Funding for Groundbreaking Sepsis Monitoring Project by EIT Health InnoStars RIS Innovation Programme Aisthesis Medical is excited to announce that its project proposal, “Personalised Real-time Interoperable Sepsis Monitoring (PRISM),” has been selected for funding by the prestigious EIT Health InnoStars RIS Innovation programme. This significant recognition distinguishes PRISM among the top 10

## Pages

- [Home](https://aisthesismed.com/) - Prevent Sepsis Before It Strikes VIOSync® is the AI-powered clinical decision support engine that uses explainable AI and digital patient twins to predict sepsis up to 48 hours earlier — saving lives, ICU resources, and costs Request a Demo Trusted by leading hospitals and technology partners Foundation Meet VIOSync® Predicting Patient Deterioration Before It Escalates
- [Careers](https://aisthesismed.com/careers/) - Careers at Aisthesis Medical Check out our open positions below and find your next opportunity. Junior Data Scientist Anywhere (UK-EU timezones) Engineering Why Join Us Join a team dedicated to using clinical AI to solve one of healthcare's most critical challenges: sepsis. We offer a chance to work on a platform that directly saves lives
- [Contact](https://aisthesismed.com/contact/) - Our Locations Talk to Our Team Have a question, proposal, or partnership idea? We’d love to hear from you. Name Email Query Type Hospital or Clinician Potential Investor Medical Device Manufacturer HR queries Other Website Message Send
- [Product](https://aisthesismed.com/product/) - Predictive AI for Life-Saving Sepsis Intervention A hospital-grade clinical decision support system integrating the Sepsis Prediction Index (SPI®) to identify sepsis risk up to 48 hours before clinical signs appear, enabling timely, life-saving intervention. Problem Every 2.8 seconds, someone dies from sepsis. Most Cases Are Detected Too Late. ¹ Global Sepsis Alliance Global sepsis cases/year
- [About Us](https://aisthesismed.com/about/) - Powering Proactive Care with Clinical AI We build robust, hospital-grade AI that provides clinicians with the time and rationale needed to act sooner - before patient deterioration escalates Overview Company Overview Aisthesis Medical was founded to address the critical gaps in early deterioration detection and response across acute care settings. We develop VIOSync®, a comprehensive
- [Research](https://aisthesismed.com/research/) - Grounded in Science. Validated in Practice. We develop and evaluate VIOSync® with real-world data, clinician partnership, and transparent methods—so hospitals can trust what they deploy. Philosophy Our Research Philosophy Built on Evidence. Driven by Collaboration. Real-World Evidence Prospective and retrospective studies across wards and ICU. Clinician Collaboration Co-designed protocols, workflow-first evaluation. Continuous Improvement Ongoing model

## Advisors + Consultants

- [Iain Miller](https://aisthesismed.com/advisor/iain-miller/)
- [Samantha Shelley](https://aisthesismed.com/advisor/samantha-shelley/)
- [Heather Carre-Skinner](https://aisthesismed.com/advisor/heather-carre-skinner/)
- [Jeff Pompeo](https://aisthesismed.com/advisor/jeff-pompeo/)
- [Argyrios Spyridis](https://aisthesismed.com/advisor/argyrios-spyridis/)
- [Adriane Thrash](https://aisthesismed.com/advisor/adriane-thrash/)
- [Paul Morton](https://aisthesismed.com/advisor/paul-morton/)
- [Erki Mölder](https://aisthesismed.com/advisor/erki-molder/)

## Careers

- [Data Scientist](https://aisthesismed.com/career/data-scientist/)

## Policies

- [Privacy Notice](https://aisthesismed.com/policy/privacy-notice/) - Last Updated October 23, 2025 Introduction Aisthesis Medical Ltd ("Aisthesis", "we", "our", or "us") is committed to protecting the privacy and security of your personal information. We safeguard the data of everyone who engages with us—including healthcare professionals, clinical and research partners, customers and their staff, suppliers, prospective employees, investors, and website visitors. This Privacy
- [Accessibility Statement](https://aisthesismed.com/policy/accessibility-statement/) - Last Updated October 23, 2025 Our Commitment to Accessibility Aisthesis Medical Ltd is committed to ensuring that our websites and digital platforms—including our main site and any associated portals, dashboards, or applications—are accessible to all users, including people with disabilities. We believe in providing an inclusive online experience that is perceivable, operable, understandable, and robust,
- [Recruitment Privacy Notice](https://aisthesismed.com/policy/recruitment-privacy-notice/) - Last Updated October 23, 2025 Introduction Aisthesis Medical Ltd ("Aisthesis", "we", "our", or "us") is committed to protecting the privacy and security of your personal information. You are receiving this Privacy Notice because you are applying for a position with us—whether as an employee, consultant, intern, or contractor. This notice explains how and why we
- [Employee Privacy Notice](https://aisthesismed.com/policy/employee-privacy-notice/) - Last Updated: October 23, 2025 Purpose Aisthesis Medical Ltd ("Aisthesis", "we", "our", or "us") is committed to protecting the privacy and security of your personal information. This privacy notice explains how we collect, use, and protect your personal information during and after your employment with us, in accordance with applicable Data Protection Legislation. "Data Protection
- [Cookies Policy](https://aisthesismed.com/policy/cookies-policy/) - Last Updated: October 23, 2025 Cookies Policy This Cookies Policy explains how Aisthesis Medical Ltd ("Aisthesis", "we", "us", or "our") uses cookies and similar technologies to recognize you when you visit our website at www.aisthesismedical.com ("Website"). It describes what these technologies are, why we use them, and your choices for controlling them. In some cases,

## Team Members

- [Ioannis Malamas](https://aisthesismed.com/team-member/ioannis-malamas/)
- [Ioannis Dimitriadis](https://aisthesismed.com/team-member/ioannis-dimitriadis/)
- [Chara Gkrantouni](https://aisthesismed.com/team-member/chara-gkrantouni/)
- [Nikolas Kougioulis](https://aisthesismed.com/team-member/nikolas-kougioulis/)
- [Anastasia Varoucha](https://aisthesismed.com/team-member/anastasia-varoucha/)
- [Vasileios Dimakopoulos](https://aisthesismed.com/team-member/auto-draft-2/)
- [Petros Mitseas](https://aisthesismed.com/team-member/auto-draft-5/)
- [Dr Savvas Vlachos](https://aisthesismed.com/team-member/dr-savvas-vlachos/)
- [Sotirios Liliopoulos](https://aisthesismed.com/team-member/auto-draft-3/)
- [Ioannis Gkouzionis](https://aisthesismed.com/team-member/auto-draft/)

## Categories

- [News](https://aisthesismed.com/category/news/)